Peritoneal Dialysis Market is expected to reach US$ 21.55 Billion by 2034

Product Segment Leading the Peritoneal Dialysis Market by Offerings

According to our new research study on “Peritoneal Dialysis Market Forecast to 2034 – Global Analysis – by Offerings, Dialysis Type, Indication, and End User,” the peritoneal dialysis market size is expected to grow from US$ 11.56 billion in 2025 to US$ 21.55 billion by 2034, with a CAGR of 7.4% during 2025–2034. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) due to diabetes and hypertension, increasing cost-effectiveness and quality of life benefits compared to in-center hemodialysis, and growing technological advancements in PD systems are driving the peritoneal dialysis market growth. 

Patients prefer home-based renal replacement therapies while seeking flexible, convenient, and effective treatment for chronic kidney disease and end-stage renal disease. The adoption of peritoneal dialysis is accelerating as patients recognize the benefits of home care, the aging population continues to grow, and kidney disorders become more common. Continuous ambulatory and automated peritoneal dialysis systems offer distinct advantages, shaping peritoneal dialysis market trends through their convenience, portability, safety features, and treatment outcomes. Clinical outcomes improve through technological advancements that combine remote monitoring with automated cyclers and enhanced dialysate formulations, making therapy easier to manage and less time-consuming. End users include hospitals, dialysis centers, and home care settings that support routine treatment delivery and specialized renal care services across diverse patient populations.

Peritoneal Dialysis Market, by Region, 2025 (%)

Peritoneal Dialysis Market Analysis Based on Segmental Evaluation:

Based on offerings, the peritoneal dialysis market is classified into product and services. In 2025, the product segment held the largest peritoneal dialysis market share. The systems offer treatment methods for dermatological conditions and aesthetic needs. The devices use noninvasive techniques that need only tiny cuts to help patients recover more quickly. The systems have proven effective for skin resurfacing, hair removal, pigmentation treatment, and scar reduction. 

The scope of the peritoneal dialysis market report includes an assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. In terms of revenue, North America dominated the peritoneal dialysis market share in 2025. 

The peritoneal dialysis market has grown in the US as a key home-based therapy for end-stage kidney disease (ESKD), supported by policy initiatives such as the Advancing American Kidney Health initiative and the ESRD Treatment Choices (ETC) model aimed at increasing home dialysis utilization. According to the United States Renal Data System (USRDS) 2024 Annual Data Report, incident PD adoption increased substantially: the percentage of incident patients starting PD increased from 8.3% in 2012 to 14.0% in 2022, reaching ~13.7% in 2022 data (17,939 patients initiating PD). Prevalent PD patients increased from 8.8% to 12.1% of dialysis patients in the year 2022. Total home dialysis (primarily PD) reached about 14.5% of prevalent dialysis patients by 2022. Improvements in outcomes include declining peritonitis-related hospitalizations and better technique survival in larger programs. PD preserves residual kidney function and offers lifestyle flexibility, with younger patients and those with cystic kidney disease more likely to choose PD, as Automated PD (APD) and patient training programs support adherence. USRDS data highlight evolving practices, including catheter placement trends (predominantly by surgeons) and reduced complications, positioning PD as an important modality amid efforts to expand home therapies for better patient-centered care and system sustainability. 

Medtronic, Vantive (formerly Baxter Kidney Care), Fresenius Medical Care AG, B. Braun SE, Nipro Corp., DaVita Healthcare Partners, Bioteque Corporation, Newsol Technologies Inc, Poly Medicure Ltd, Utah Medical Products, Inc, and Awak Technologies are among the leading companies profiled in the peritoneal dialysis market report. 

By dialysis type, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on indication, the market is segmented into end-stage renal disease (ESRD), acute kidney injury, and chronic kidney disease. In terms of end users, the market is categorized into hospitals, dialysis centers and clinics, homecare settings, and others. By geography, the market is divided into North America (the US and Canada), Europe (France, Germany, the UK, Spain, Italy, Russia and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Hong Kong and the Rest of Asia Pacific), Latin America (Brazil, Argentina, Colombia, Mexico and the Rest of Latin America), and the Middle East and Africa (South Africa, GCC Countries, and the Rest of Middle East and Africa).